Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1771-1776

  Abdalla, Fathi ^a,c   Boder, Jamela ^a,c   Markus, Rabia ^b   Hashmi, Hussein ^c   Buhmeida, Abdelbaset ^a   Collan, Yrjö ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Tripoli Medical Center   (Finland)

^c African Oncology Institute   (Libyan Arab Jamahiriya)

Author keywords

Clinicopathological features; Libyan female breast cancer; Nuclear morphometry; Survival

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 67650065361     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lester J: Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies. Clin J Oncol Nurs 11: 619-622, 2007.
2. Draper L: Breast cancer: trends, risks, treatments, and effects. Aohn J 54: 445-451, 2006.
3. McBride R, Hershman D, Tsai WY, Jacobson JS, Grann V and Neugut AI: Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. Cancer 110: 1201-1208, 2007. (Pubitemid 47435589)
4. Collan Y, Kuopio T and Alanen K: Scope and concepts of quantitive histopathology. Acta Stereol 11: 3-23, 1992.
5. Page DL: Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol 15: 334-349, 1991.
6. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC and Wilbur DC: Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-198, 1995.
7. Boon ME, Trott PA, van Kaam H, Kurver PJ, Leach A and Baak JP: Morphometry and cytodiagnosis of breast lesions. Virchows Arch A Pathol Anat Histol 396: 9-18, 1982.
8. Schondorf H and Naujoks H: Determining the nuclear area in normal breast epithelia and in the nuclei of mammary carcinomas. J Cancer Res Clin Oncol 109: 241-244, 1985. (Pubitemid 15096526)
9. Baak JP, Van Dop H, Kurver PH and Hermans J: The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374-382, 1985. (Pubitemid 15031663)
10. van Diest PJ and Baak JP: The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 22: 326-330, 1991.
11. Romppanen T and Collan Y: Practical guidelines for a morphometric study. Acta Stereol 2: 274-297, 1983.
12. Kronqvist P, Kuopio T and Collan Y: Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. Br J Cancer 78: 800-805, 1998. (Pubitemid 28418317)
13. Ikpatt O, Kuopio T and Collan Y: Nuclear morphometry in African breast cancer. Image Analys Stereol 21: 145-150, 2002.
14. Baak JP, Kurver PH, De Snoo-Niewlaat AJ, De Graef S, Makkink B and Boon ME: Prognostic indicators in breast cancer - morphometric methods. Histopathology 6: 327-339, 1982.
15. Aaltomaa S, Lipponen P, Eskelinen M, Alhava E and Syrjanen K: Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer. Eur J Surg 157: 319-324, 1991.
16. Ladekarl M and Sorensen FB: Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast. APMIS 101: 895-903, 1993. (Pubitemid 24063728)
17. Kronqvist P, Collan Y, Kuopio T and Kujari H: Nuclear morphometry in breast cancer: the influence of sampling rules and freezing of samples. Mod Pathol 8: 187-192, 1995.
18. Kronqvist P, Kuopio T, Collan Y, Horvath C and Tamm U: The reproducibility of nuclear morphometric measurements in invasive breast carcinoma. Anal Cell Pathol 15: 47-59, 1997. (Pubitemid 27448892)
19. Ladekarl M: Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts. Cancer 75: 2114-2122, 1995.
20. Ikpatt OF, Kuopio T, Ndoma-Egba R and Collan Y: Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 22: 3005-3012, 2002. (Pubitemid 36069350)
21. Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K and Mitchell EP: Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 110: 876-884, 2007. (Pubitemid 47257667)
22. Ikpatt F and Olopade O: In: Genetics of breast cancer in women of African descent: an overview. O. Olopade, C. Falkson, and C. Williams (eds.). Breast cancer in women of African descent, pp. 22-37. New York: Springer, Berlin, Chapter 2, 2005.
23. Jobling MA, Hurles M and Tyler-Smith C: In: Human evolutionary genetics. Origin, peoples and disease. Especially chapters 9 (The distribution of diversity), 10 (Agricultural expansion), 13 (Understanding the past and future of phenotypic variation), and 14 (Health implications of our evolutionary heritage). M. Jobling, M. Hurles, and C. Tyler-Smith (eds.). Human evolutionary genetics, pp. 272-471. New York and Abingdon: Garland Publishing, 2004.
24. Giardina C, Renzulli G, Serio G, Caniglia DM, Lettini T, Ferri C, D'Eredita G, Ricco R and Delfino VP: Nuclear morphometry in node-negative breast carcinoma. Anal Quant Cytol Histol 18: 374-382, 1996. (Pubitemid 26346581)
25. Abdalla F, Boder J, Buhmeida A, Hashmi H, Elzagheid A and Collan Y: Nuclear morphometry in FNABs of breast disease in Libyans. Anticancer Res 28: 3985-3990, 2008.